TP53 and glioma: In summary, this study demonstrated that UBE2C is overexpressed in TMZ-resistant glioma tissues and cells and that the overexpression of UBE2C significantly enhances the resistance of glioma cells to TMZ by limiting p53 expression and facilitating aerobic glycolysis.